Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03293381 · ClinicalTrials.gov registry record
Electrogram-Guided Myocardial Advanced Phenotyping
A clinical trial, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- 35
- Enrollment target
NCT03293381: Clinical Trial study, sponsored by University of Pennsylvania.
NCT03293381 is a clinical trial that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03293381 was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- 35 participants
- Enrollment target
Study Summary
Fluoroscopy guided EMB and EAM guided EMB on all patients meeting existing guidelines for biopsy.
Interventions
- DEVICE additional biopsies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2018-11-30 |
| Est. Completion | 2024-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03293381
The ClinicalTrials.gov registry entry for NCT03293381 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which additional biopsies is the first listed.
NCT03293381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03293381 about?
NCT03293381 is a clinical study titled "Electrogram-Guided Myocardial Advanced Phenotyping". Fluoroscopy guided EMB and EAM guided EMB on all patients meeting existing guidelines for biopsy.
What is the current status of trial NCT03293381?
This trial is currently terminated. The enrollment target is 35 participants. The study started on 2018-11-30. Estimated completion is 2024-11-30.
What interventions are being tested in trial NCT03293381?
The interventions under investigation include: additional biopsies (DEVICE).
Who is sponsoring clinical trial NCT03293381?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.